Q1 2025 Earnings Call Transcript May 8, 2025 Pacific Biosciences of California, Inc. beats earnings expectations. Reported ...

CEO Christian Henry reported Q1 2025 revenue of $37.2 million, aligning with internal expectations. Instrument revenue was $11 million, with 12 Revio and 28 Vega systems shipped during the quarter.

Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q1 CY2025 results , but sales fell by 4.3% year on ...